nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluoxymesterone—PRLR—cortex of kidney—kidney cancer	0.0307	0.276	CbGeAlD
Fluoxymesterone—Coma hepatic—Capecitabine—kidney cancer	0.0263	0.0708	CcSEcCtD
Fluoxymesterone—Oligospermia—Gemcitabine—kidney cancer	0.0229	0.0616	CcSEcCtD
Fluoxymesterone—Azoospermia—Gemcitabine—kidney cancer	0.0178	0.0479	CcSEcCtD
Fluoxymesterone—Blood cholesterol increased—Everolimus—kidney cancer	0.0177	0.0478	CcSEcCtD
Fluoxymesterone—NR3C1—urine—kidney cancer	0.015	0.135	CbGeAlD
Fluoxymesterone—Menstruation irregular—Everolimus—kidney cancer	0.0129	0.0348	CcSEcCtD
Fluoxymesterone—Hirsutism—Everolimus—kidney cancer	0.0123	0.0332	CcSEcCtD
Fluoxymesterone—Hirsutism—Erlotinib—kidney cancer	0.0119	0.032	CcSEcCtD
Fluoxymesterone—Oligospermia—Doxorubicin—kidney cancer	0.0101	0.0273	CcSEcCtD
Fluoxymesterone—Coagulopathy—Everolimus—kidney cancer	0.00918	0.0247	CcSEcCtD
Fluoxymesterone—Amenorrhoea—Everolimus—kidney cancer	0.00814	0.0219	CcSEcCtD
Fluoxymesterone—Azoospermia—Doxorubicin—kidney cancer	0.00788	0.0212	CcSEcCtD
Fluoxymesterone—Amcinonide—ANXA1—kidney cancer	0.00757	0.326	CrCbGaD
Fluoxymesterone—Coagulopathy—Dactinomycin—kidney cancer	0.00726	0.0196	CcSEcCtD
Fluoxymesterone—SHBG—gonad—kidney cancer	0.00632	0.0568	CbGeAlD
Fluoxymesterone—Hirsutism—Capecitabine—kidney cancer	0.00566	0.0153	CcSEcCtD
Fluoxymesterone—Gynaecomastia—Sorafenib—kidney cancer	0.00555	0.015	CcSEcCtD
Fluoxymesterone—AR—renal system—kidney cancer	0.00506	0.0455	CbGeAlD
Fluoxymesterone—ESR1—renal system—kidney cancer	0.00497	0.0446	CbGeAlD
Fluoxymesterone—AR—kidney—kidney cancer	0.00489	0.044	CbGeAlD
Fluoxymesterone—ESR1—kidney—kidney cancer	0.0048	0.0432	CbGeAlD
Fluoxymesterone—AR—cortex of kidney—kidney cancer	0.00477	0.0428	CbGeAlD
Fluoxymesterone—Haemoglobin—Pazopanib—kidney cancer	0.00457	0.0123	CcSEcCtD
Fluoxymesterone—Haemorrhage—Pazopanib—kidney cancer	0.00455	0.0123	CcSEcCtD
Fluoxymesterone—AR—gonad—kidney cancer	0.00454	0.0408	CbGeAlD
Fluoxymesterone—AR—cardiac atrium—kidney cancer	0.00453	0.0407	CbGeAlD
Fluoxymesterone—ESR1—gonad—kidney cancer	0.00446	0.04	CbGeAlD
Fluoxymesterone—Coagulopathy—Capecitabine—kidney cancer	0.00423	0.0114	CcSEcCtD
Fluoxymesterone—NR3C1—nephron tubule—kidney cancer	0.00403	0.0362	CbGeAlD
Fluoxymesterone—Alopecia—Pazopanib—kidney cancer	0.00402	0.0108	CcSEcCtD
Fluoxymesterone—NR3C1—renal system—kidney cancer	0.00367	0.0329	CbGeAlD
Fluoxymesterone—Haemoglobin—Vinblastine—kidney cancer	0.00362	0.00976	CcSEcCtD
Fluoxymesterone—Haemoglobin—Everolimus—kidney cancer	0.00361	0.00972	CcSEcCtD
Fluoxymesterone—Haemorrhage—Vinblastine—kidney cancer	0.0036	0.00971	CcSEcCtD
Fluoxymesterone—Anaphylactoid reaction—Gemcitabine—kidney cancer	0.00359	0.00968	CcSEcCtD
Fluoxymesterone—Haemorrhage—Everolimus—kidney cancer	0.00359	0.00968	CcSEcCtD
Fluoxymesterone—Anxiety—Temsirolimus—kidney cancer	0.00356	0.00961	CcSEcCtD
Fluoxymesterone—NR3C1—kidney—kidney cancer	0.00354	0.0318	CbGeAlD
Fluoxymesterone—Haemoglobin—Erlotinib—kidney cancer	0.00348	0.00938	CcSEcCtD
Fluoxymesterone—Haemorrhage—Erlotinib—kidney cancer	0.00346	0.00934	CcSEcCtD
Fluoxymesterone—NR3C1—cortex of kidney—kidney cancer	0.00345	0.031	CbGeAlD
Fluoxymesterone—Anaphylactic shock—Temsirolimus—kidney cancer	0.00343	0.00924	CcSEcCtD
Fluoxymesterone—NR3C1—gonad—kidney cancer	0.00329	0.0295	CbGeAlD
Fluoxymesterone—NR3C1—cardiac atrium—kidney cancer	0.00328	0.0295	CbGeAlD
Fluoxymesterone—Hydrocortisone—ANXA1—kidney cancer	0.00319	0.138	CrCbGaD
Fluoxymesterone—Alopecia—Vinblastine—kidney cancer	0.00318	0.00858	CcSEcCtD
Fluoxymesterone—Alopecia—Everolimus—kidney cancer	0.00317	0.00855	CcSEcCtD
Fluoxymesterone—Haemoglobin—Sorafenib—kidney cancer	0.00313	0.00844	CcSEcCtD
Fluoxymesterone—Haemorrhage—Sorafenib—kidney cancer	0.00312	0.0084	CcSEcCtD
Fluoxymesterone—Seborrhoeic dermatitis—Doxorubicin—kidney cancer	0.00311	0.00839	CcSEcCtD
Fluoxymesterone—Alopecia—Erlotinib—kidney cancer	0.00306	0.00825	CcSEcCtD
Fluoxymesterone—Haemoglobin—Sunitinib—kidney cancer	0.00301	0.00812	CcSEcCtD
Fluoxymesterone—Haemorrhage—Sunitinib—kidney cancer	0.003	0.00808	CcSEcCtD
Fluoxymesterone—Paraesthesia—Pazopanib—kidney cancer	0.0029	0.00782	CcSEcCtD
Fluoxymesterone—Alopecia—Sorafenib—kidney cancer	0.00275	0.00742	CcSEcCtD
Fluoxymesterone—Anxiety—Everolimus—kidney cancer	0.00265	0.00715	CcSEcCtD
Fluoxymesterone—Alopecia—Sunitinib—kidney cancer	0.00265	0.00714	CcSEcCtD
Fluoxymesterone—Libido decreased—Capecitabine—kidney cancer	0.00258	0.00695	CcSEcCtD
Fluoxymesterone—Anxiety—Erlotinib—kidney cancer	0.00256	0.00689	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Temsirolimus—kidney cancer	0.00253	0.00681	CcSEcCtD
Fluoxymesterone—Alopecia—Dactinomycin—kidney cancer	0.00251	0.00676	CcSEcCtD
Fluoxymesterone—Haemoglobin—Gemcitabine—kidney cancer	0.00242	0.00652	CcSEcCtD
Fluoxymesterone—Jaundice cholestatic—Doxorubicin—kidney cancer	0.00241	0.00651	CcSEcCtD
Fluoxymesterone—Amenorrhoea—Doxorubicin—kidney cancer	0.00241	0.00651	CcSEcCtD
Fluoxymesterone—Haemorrhage—Gemcitabine—kidney cancer	0.00241	0.00648	CcSEcCtD
Fluoxymesterone—Dexamethasone—ANXA1—kidney cancer	0.00238	0.103	CrCbGaD
Fluoxymesterone—Disturbance in sexual arousal—Capecitabine—kidney cancer	0.00237	0.00639	CcSEcCtD
Fluoxymesterone—Paraesthesia—Vinblastine—kidney cancer	0.0023	0.0062	CcSEcCtD
Fluoxymesterone—Paraesthesia—Everolimus—kidney cancer	0.00229	0.00617	CcSEcCtD
Fluoxymesterone—Alopecia—Vincristine—kidney cancer	0.00224	0.00604	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Sorafenib—kidney cancer	0.00221	0.00597	CcSEcCtD
Fluoxymesterone—Headache—Temsirolimus—kidney cancer	0.00215	0.00579	CcSEcCtD
Fluoxymesterone—Alopecia—Gemcitabine—kidney cancer	0.00213	0.00573	CcSEcCtD
Fluoxymesterone—Nausea—Temsirolimus—kidney cancer	0.00204	0.00549	CcSEcCtD
Fluoxymesterone—Haemoglobin—Paclitaxel—kidney cancer	0.00202	0.00546	CcSEcCtD
Fluoxymesterone—Headache—Pazopanib—kidney cancer	0.00202	0.00545	CcSEcCtD
Fluoxymesterone—Haemorrhage—Paclitaxel—kidney cancer	0.00201	0.00543	CcSEcCtD
Fluoxymesterone—Nausea—Pazopanib—kidney cancer	0.00192	0.00517	CcSEcCtD
Fluoxymesterone—Paraesthesia—Sunitinib—kidney cancer	0.00191	0.00516	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Vinblastine—kidney cancer	0.00189	0.00508	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Everolimus—kidney cancer	0.00188	0.00506	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Vincristine—kidney cancer	0.0018	0.00486	CcSEcCtD
Fluoxymesterone—Alopecia—Paclitaxel—kidney cancer	0.00178	0.0048	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Gemcitabine—kidney cancer	0.00171	0.00461	CcSEcCtD
Fluoxymesterone—Haemoglobin—Capecitabine—kidney cancer	0.00166	0.00448	CcSEcCtD
Fluoxymesterone—Haemorrhage—Capecitabine—kidney cancer	0.00165	0.00446	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Sorafenib—kidney cancer	0.00163	0.0044	CcSEcCtD
Fluoxymesterone—Paraesthesia—Vincristine—kidney cancer	0.00162	0.00436	CcSEcCtD
Fluoxymesterone—Headache—Vinblastine—kidney cancer	0.0016	0.00432	CcSEcCtD
Fluoxymesterone—Headache—Everolimus—kidney cancer	0.0016	0.00431	CcSEcCtD
Fluoxymesterone—Anaphylactoid reaction—Doxorubicin—kidney cancer	0.00159	0.00429	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Sunitinib—kidney cancer	0.00157	0.00423	CcSEcCtD
Fluoxymesterone—Headache—Erlotinib—kidney cancer	0.00154	0.00416	CcSEcCtD
Fluoxymesterone—Paraesthesia—Gemcitabine—kidney cancer	0.00153	0.00414	CcSEcCtD
Fluoxymesterone—Nausea—Vinblastine—kidney cancer	0.00152	0.0041	CcSEcCtD
Fluoxymesterone—Nausea—Everolimus—kidney cancer	0.00151	0.00408	CcSEcCtD
Fluoxymesterone—Anxiety—Paclitaxel—kidney cancer	0.00149	0.00401	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Dactinomycin—kidney cancer	0.00149	0.004	CcSEcCtD
Fluoxymesterone—Nausea—Erlotinib—kidney cancer	0.00146	0.00394	CcSEcCtD
Fluoxymesterone—Alopecia—Capecitabine—kidney cancer	0.00146	0.00394	CcSEcCtD
Fluoxymesterone—Triamcinolone—BCHE—kidney cancer	0.00145	0.0627	CrCbGaD
Fluoxymesterone—Anaphylactic shock—Paclitaxel—kidney cancer	0.00143	0.00386	CcSEcCtD
Fluoxymesterone—Headache—Sorafenib—kidney cancer	0.00139	0.00374	CcSEcCtD
Fluoxymesterone—Clobetasol propionate—CYP1A1—kidney cancer	0.00136	0.0589	CrCbGaD
Fluoxymesterone—Headache—Sunitinib—kidney cancer	0.00133	0.0036	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Vincristine—kidney cancer	0.00133	0.00358	CcSEcCtD
Fluoxymesterone—Nausea—Sorafenib—kidney cancer	0.00132	0.00354	CcSEcCtD
Fluoxymesterone—Paraesthesia—Paclitaxel—kidney cancer	0.00129	0.00346	CcSEcCtD
Fluoxymesterone—Nausea—Sunitinib—kidney cancer	0.00127	0.00341	CcSEcCtD
Fluoxymesterone—Anxiety—Capecitabine—kidney cancer	0.00122	0.00329	CcSEcCtD
Fluoxymesterone—Nausea—Dactinomycin—kidney cancer	0.0012	0.00323	CcSEcCtD
Fluoxymesterone—Headache—Vincristine—kidney cancer	0.00113	0.00304	CcSEcCtD
Fluoxymesterone—Haemoglobin—Doxorubicin—kidney cancer	0.00107	0.00289	CcSEcCtD
Fluoxymesterone—Headache—Gemcitabine—kidney cancer	0.00107	0.00289	CcSEcCtD
Fluoxymesterone—Nausea—Vincristine—kidney cancer	0.00107	0.00288	CcSEcCtD
Fluoxymesterone—Haemorrhage—Doxorubicin—kidney cancer	0.00107	0.00287	CcSEcCtD
Fluoxymesterone—Paraesthesia—Capecitabine—kidney cancer	0.00105	0.00284	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Paclitaxel—kidney cancer	0.00105	0.00284	CcSEcCtD
Fluoxymesterone—Nausea—Gemcitabine—kidney cancer	0.00102	0.00274	CcSEcCtD
Fluoxymesterone—Alopecia—Doxorubicin—kidney cancer	0.000942	0.00254	CcSEcCtD
Fluoxymesterone—Headache—Paclitaxel—kidney cancer	0.000897	0.00242	CcSEcCtD
Fluoxymesterone—Megestrol acetate—ABCB1—kidney cancer	0.000882	0.0381	CrCbGaD
Fluoxymesterone—Hypersensitivity—Capecitabine—kidney cancer	0.000865	0.00233	CcSEcCtD
Fluoxymesterone—Nausea—Paclitaxel—kidney cancer	0.00085	0.00229	CcSEcCtD
Fluoxymesterone—Anxiety—Doxorubicin—kidney cancer	0.000787	0.00212	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Doxorubicin—kidney cancer	0.000757	0.00204	CcSEcCtD
Fluoxymesterone—Headache—Capecitabine—kidney cancer	0.000736	0.00198	CcSEcCtD
Fluoxymesterone—Nausea—Capecitabine—kidney cancer	0.000698	0.00188	CcSEcCtD
Fluoxymesterone—Paraesthesia—Doxorubicin—kidney cancer	0.00068	0.00183	CcSEcCtD
Fluoxymesterone—Triamcinolone—PTGS2—kidney cancer	0.00067	0.0289	CrCbGaD
Fluoxymesterone—Progesterone—CYP1A1—kidney cancer	0.000559	0.0241	CrCbGaD
Fluoxymesterone—Hypersensitivity—Doxorubicin—kidney cancer	0.000558	0.0015	CcSEcCtD
Fluoxymesterone—Betamethasone—PTGS2—kidney cancer	0.000549	0.0237	CrCbGaD
Fluoxymesterone—Spironolactone—ABCB1—kidney cancer	0.000549	0.0237	CrCbGaD
Fluoxymesterone—Testosterone—CYP1A1—kidney cancer	0.000528	0.0228	CrCbGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—CTNNB1—kidney cancer	0.000523	0.00106	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—RELA—kidney cancer	0.000522	0.00106	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—CCND1—kidney cancer	0.00052	0.00105	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—JUN—kidney cancer	0.000519	0.00105	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—CTNNB1—kidney cancer	0.000515	0.00104	CbGpPWpGaD
Fluoxymesterone—ESR1—LKB1 signaling events—TP53—kidney cancer	0.000514	0.00104	CbGpPWpGaD
Fluoxymesterone—Dexamethasone—CYP1A1—kidney cancer	0.000511	0.022	CrCbGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—PTEN—kidney cancer	0.00051	0.00103	CbGpPWpGaD
Fluoxymesterone—Norethindrone—ABCB1—kidney cancer	0.000509	0.022	CrCbGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—BRAF—kidney cancer	0.000508	0.00103	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—PTEN—kidney cancer	0.000502	0.00102	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—TSC2—kidney cancer	0.0005	0.00101	CbGpPWpGaD
Fluoxymesterone—ESR1—Leptin signaling pathway—CCND1—kidney cancer	0.0005	0.00101	CbGpPWpGaD
Fluoxymesterone—ESR1—ATF-2 transcription factor network—MAPK3—kidney cancer	0.0005	0.00101	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—JUNB—kidney cancer	0.000498	0.00101	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—PAK1—kidney cancer	0.000498	0.00101	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—CDH1—kidney cancer	0.000497	0.00101	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—kidney cancer	0.000494	0.001	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—BRCA2—kidney cancer	0.000494	0.000999	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—CDKN2B—kidney cancer	0.00049	0.000991	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of nuclear SMAD2/3 signaling—MYC—kidney cancer	0.00049	0.00099	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—ABCB1—kidney cancer	0.000479	0.000968	CbGpPWpGaD
Fluoxymesterone—Prednisolone—ABCB1—kidney cancer	0.000476	0.0206	CrCbGaD
Fluoxymesterone—ESR1—ATF-2 transcription factor network—MAPK1—kidney cancer	0.000475	0.000961	CbGpPWpGaD
Fluoxymesterone—Headache—Doxorubicin—kidney cancer	0.000474	0.00128	CcSEcCtD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—TSC2—kidney cancer	0.000471	0.000953	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—IL2—kidney cancer	0.00047	0.000951	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of nuclear SMAD2/3 signaling—JUN—kidney cancer	0.000469	0.000949	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—TSC2—kidney cancer	0.000469	0.000948	CbGpPWpGaD
Fluoxymesterone—Betamethasone—ABCB1—kidney cancer	0.000467	0.0201	CrCbGaD
Fluoxymesterone—NR3C1—Regulation of nuclear SMAD2/3 signaling—JUN—kidney cancer	0.000462	0.000934	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—EIF5B—kidney cancer	0.000461	0.000932	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—JUN—kidney cancer	0.000458	0.000925	CbGpPWpGaD
Fluoxymesterone—ESR1—Validated nuclear estrogen receptor alpha network—MYC—kidney cancer	0.000455	0.000921	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—EIF5B—kidney cancer	0.000454	0.000918	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—HIF1A—kidney cancer	0.000453	0.000917	CbGpPWpGaD
Fluoxymesterone—Nausea—Doxorubicin—kidney cancer	0.00045	0.00121	CcSEcCtD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—APC—kidney cancer	0.000448	0.000906	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of Telomerase—MAPK3—kidney cancer	0.000446	0.000902	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—KIT—kidney cancer	0.000442	0.000894	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of Telomerase—MYC—kidney cancer	0.000434	0.000877	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of Telomerase—MAPK1—kidney cancer	0.000424	0.000858	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—MYC—kidney cancer	0.000424	0.000857	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—MYC—kidney cancer	0.000417	0.000844	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—KIT—kidney cancer	0.000414	0.000838	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—MTOR—kidney cancer	0.000414	0.000838	CbGpPWpGaD
Fluoxymesterone—ESR1—Leptin signaling pathway—MAPK3—kidney cancer	0.000412	0.000834	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—IGF2—kidney cancer	0.000407	0.000824	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—CDH1—kidney cancer	0.000407	0.000822	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CDKN2B—kidney cancer	0.000406	0.00082	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—IGF1R—kidney cancer	0.000394	0.000797	CbGpPWpGaD
Fluoxymesterone—ESR1—Leptin signaling pathway—MAPK1—kidney cancer	0.000392	0.000793	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—BRAF—kidney cancer	0.000391	0.000791	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—JUNB—kidney cancer	0.000388	0.000785	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—EEF2—kidney cancer	0.000385	0.000779	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—CDH1—kidney cancer	0.000383	0.000775	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—MAPK3—kidney cancer	0.000378	0.000765	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of nuclear SMAD2/3 signaling—MYC—kidney cancer	0.000377	0.000763	CbGpPWpGaD
Fluoxymesterone—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—kidney cancer	0.000371	0.000751	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—CCND1—kidney cancer	0.000371	0.00075	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—JUN—kidney cancer	0.00037	0.000748	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—TET2—kidney cancer	0.000369	0.000747	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—CTNNB1—kidney cancer	0.000367	0.000743	CbGpPWpGaD
Fluoxymesterone—Hydrocortisone—ABCB1—kidney cancer	0.000364	0.0157	CrCbGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—JUN—kidney cancer	0.00036	0.000729	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—MAPK1—kidney cancer	0.00036	0.000728	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—PTEN—kidney cancer	0.000358	0.000724	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—CTNNB1—kidney cancer	0.000358	0.000723	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—OR4C13—kidney cancer	0.000352	0.000712	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	0.000352	0.000711	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—TP53—kidney cancer	0.000348	0.000704	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	0.000348	0.000703	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—RAF1—kidney cancer	0.000347	0.000701	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—RELA—kidney cancer	0.000345	0.000698	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—APC—kidney cancer	0.000345	0.000698	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—ERBB2—kidney cancer	0.000343	0.000694	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—TP53—kidney cancer	0.000343	0.000693	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—PTGS2—kidney cancer	0.00034	0.000688	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—MTOR—kidney cancer	0.000339	0.000685	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—CD4—kidney cancer	0.000338	0.000684	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—TCEB1—kidney cancer	0.000338	0.000683	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—TCEB2—kidney cancer	0.000338	0.000683	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—RAF1—kidney cancer	0.000325	0.000657	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—HIF1A—kidney cancer	0.000324	0.000656	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—TSC2—kidney cancer	0.000324	0.000654	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—VEGFA—kidney cancer	0.000323	0.000654	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	0.000322	0.000651	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—ERBB2—kidney cancer	0.000322	0.00065	CbGpPWpGaD
Fluoxymesterone—Dexamethasone—PTGS2—kidney cancer	0.000319	0.0138	CrCbGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—MTOR—kidney cancer	0.000319	0.000645	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—CDKN1B—kidney cancer	0.000318	0.000643	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—MTOR—kidney cancer	0.000317	0.000642	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—CDKN2B—kidney cancer	0.000316	0.000639	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—VEGFA—kidney cancer	0.000315	0.000637	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—CTNNB1—kidney cancer	0.000314	0.000635	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—IL2—kidney cancer	0.000311	0.000629	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—KDR—kidney cancer	0.00031	0.000627	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	0.000307	0.000621	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	0.000307	0.00062	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	0.000304	0.000615	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—JUN—kidney cancer	0.000303	0.000612	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—TP53—kidney cancer	0.000302	0.000611	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—CTNNB1—kidney cancer	0.0003	0.000607	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—LATS1—kidney cancer	0.0003	0.000606	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—JUNB—kidney cancer	0.000299	0.000605	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—CDKN1B—kidney cancer	0.000298	0.000602	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—MYC—kidney cancer	0.000297	0.000601	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—EEF2—kidney cancer	0.000297	0.0006	CbGpPWpGaD
Fluoxymesterone—Progesterone—ABCB1—kidney cancer	0.000297	0.0128	CrCbGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	0.000297	0.0006	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—JUNB—kidney cancer	0.000294	0.000595	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—PTEN—kidney cancer	0.000293	0.000592	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—EEF2—kidney cancer	0.000292	0.000591	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—MAPK1—kidney cancer	0.000291	0.000588	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—APC—kidney cancer	0.000286	0.000578	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—KIT—kidney cancer	0.000286	0.000578	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—CCND1—kidney cancer	0.000286	0.000578	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—JUN—kidney cancer	0.000285	0.000576	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—TET2—kidney cancer	0.000285	0.000576	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—CTNNB1—kidney cancer	0.000283	0.000572	CbGpPWpGaD
Fluoxymesterone—Testosterone—ABCB1—kidney cancer	0.000281	0.0121	CrCbGaD
Fluoxymesterone—NR3C1—Gene Expression—TET2—kidney cancer	0.00028	0.000567	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—PTEN—kidney cancer	0.000276	0.000558	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—KRAS—kidney cancer	0.000275	0.000556	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—RPL14—kidney cancer	0.000275	0.000555	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—PTEN—kidney cancer	0.000274	0.000555	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—JUN—kidney cancer	0.000273	0.000553	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—POMC—kidney cancer	0.000272	0.00055	CbGpPWpGaD
Fluoxymesterone—Dexamethasone—ABCB1—kidney cancer	0.000272	0.0117	CrCbGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—CTNNB1—kidney cancer	0.000271	0.000549	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	0.000271	0.000548	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—BRAF—kidney cancer	0.000269	0.000543	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	0.000268	0.000542	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	0.000268	0.000542	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—kidney cancer	0.000262	0.00053	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—TCEB2—kidney cancer	0.00026	0.000526	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—TCEB1—kidney cancer	0.00026	0.000526	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—TCEB2—kidney cancer	0.000256	0.000518	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—TCEB1—kidney cancer	0.000256	0.000518	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—AMER1—kidney cancer	0.000255	0.000515	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	0.000253	0.000512	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—MAPK3—kidney cancer	0.00025	0.000506	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—VEGFA—kidney cancer	0.000249	0.000504	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	0.000248	0.000502	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	0.000246	0.000498	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—TP53—kidney cancer	0.000244	0.000494	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—CDKN2B—kidney cancer	0.000243	0.000492	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	0.000241	0.000488	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—CDKN2B—kidney cancer	0.00024	0.000485	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—VEGFA—kidney cancer	0.000239	0.000483	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—MAPK1—kidney cancer	0.000238	0.000481	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	0.000237	0.000479	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	0.000236	0.000478	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	0.000234	0.000474	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—MAPK3—kidney cancer	0.000234	0.000474	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—MYC—kidney cancer	0.000229	0.000463	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	0.000228	0.000462	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	0.000228	0.000461	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—KRAS—kidney cancer	0.000225	0.000454	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—RAF1—kidney cancer	0.000224	0.000453	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—MAPK1—kidney cancer	0.000224	0.000453	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—EIF4EBP1—kidney cancer	0.000224	0.000453	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—HSPB1—kidney cancer	0.000224	0.000453	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—RELA—kidney cancer	0.000223	0.000451	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—MAPK1—kidney cancer	0.000223	0.000451	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—ERBB2—kidney cancer	0.000222	0.000449	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—MTOR—kidney cancer	0.000219	0.000443	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CER1—kidney cancer	0.000213	0.000432	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—GPC3—kidney cancer	0.000213	0.000432	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—KRAS—kidney cancer	0.000212	0.000428	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—RPL14—kidney cancer	0.000212	0.000428	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—KRAS—kidney cancer	0.000211	0.000426	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	0.000209	0.000423	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—RPL14—kidney cancer	0.000208	0.000421	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—PSMD7—kidney cancer	0.000208	0.000421	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—PIK3CA—kidney cancer	0.000206	0.000417	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	0.000206	0.000417	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CDKN1B—kidney cancer	0.000205	0.000416	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	0.000202	0.000409	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—IL2—kidney cancer	0.000201	0.000407	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CCND1—kidney cancer	0.000196	0.000396	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—JUN—kidney cancer	0.000196	0.000396	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	0.000195	0.000395	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CTNNB1—kidney cancer	0.000194	0.000393	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—PIK3CA—kidney cancer	0.000193	0.000391	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	0.00019	0.000384	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—PTEN—kidney cancer	0.000189	0.000383	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—TP53—kidney cancer	0.000188	0.000381	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—JUNB—kidney cancer	0.000187	0.000378	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	0.000186	0.000376	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—SFRP2—kidney cancer	0.000181	0.000367	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	0.000175	0.000355	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—EIF4EBP1—kidney cancer	0.000172	0.000349	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—HSPB1—kidney cancer	0.000172	0.000349	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—VEGFA—kidney cancer	0.000171	0.000346	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—EIF4EBP1—kidney cancer	0.00017	0.000343	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—HSPB1—kidney cancer	0.00017	0.000343	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—MAPK3—kidney cancer	0.000162	0.000327	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	0.000161	0.000326	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—PSMD7—kidney cancer	0.00016	0.000324	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—PSMD7—kidney cancer	0.000158	0.000319	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—MYC—kidney cancer	0.000157	0.000318	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	0.000156	0.000315	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—MAPK1—kidney cancer	0.000154	0.000311	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—CDKN2B—kidney cancer	0.000152	0.000308	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—AKAP13—kidney cancer	0.000146	0.000296	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CASP2—kidney cancer	0.000146	0.000296	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—KRAS—kidney cancer	0.000145	0.000294	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—JUNB—kidney cancer	0.000144	0.000291	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—JUNB—kidney cancer	0.000142	0.000287	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—GRB7—kidney cancer	0.000134	0.000271	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—PIK3CA—kidney cancer	0.000133	0.00027	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—TP53—kidney cancer	0.000129	0.000261	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—ITPR2—kidney cancer	0.000124	0.000252	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—MYC—kidney cancer	0.000122	0.000248	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—CDKN2B—kidney cancer	0.000117	0.000237	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—CDKN2B—kidney cancer	0.000115	0.000233	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CTNNA1—kidney cancer	0.000113	0.000228	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—HSPB1—kidney cancer	0.000112	0.000227	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—EIF4EBP1—kidney cancer	0.000112	0.000227	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—TSC1—kidney cancer	0.000104	0.000211	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PSMD7—kidney cancer	0.000104	0.000211	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—ANXA1—kidney cancer	0.000104	0.000211	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—FLT1—kidney cancer	0.000101	0.000204	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—MYC—kidney cancer	9.43e-05	0.000191	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PAK1—kidney cancer	9.36e-05	0.000189	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—JUNB—kidney cancer	9.36e-05	0.000189	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—MYC—kidney cancer	9.29e-05	0.000188	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—IGF2—kidney cancer	7.65e-05	0.000155	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CDKN2B—kidney cancer	7.62e-05	0.000154	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—IGF1R—kidney cancer	7.4e-05	0.00015	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—HIF1A—kidney cancer	6.09e-05	0.000123	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—TSC2—kidney cancer	6.07e-05	0.000123	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—MAPK3—kidney cancer	6.06e-05	0.000123	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—MYC—kidney cancer	5.89e-05	0.000119	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—KDR—kidney cancer	5.82e-05	0.000118	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—APC—kidney cancer	5.37e-05	0.000108	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—KIT—kidney cancer	5.37e-05	0.000108	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—POMC—kidney cancer	5.11e-05	0.000103	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—BRAF—kidney cancer	5.04e-05	0.000102	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—MAPK3—kidney cancer	4.67e-05	9.44e-05	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—MAPK3—kidney cancer	4.6e-05	9.3e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—MYC—kidney cancer	4.54e-05	9.18e-05	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—MYC—kidney cancer	4.47e-05	9.04e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—RAF1—kidney cancer	4.21e-05	8.52e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—RELA—kidney cancer	4.19e-05	8.48e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—ERBB2—kidney cancer	4.17e-05	8.42e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—MTOR—kidney cancer	4.11e-05	8.31e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CDKN1B—kidney cancer	3.86e-05	7.8e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—IL2—kidney cancer	3.78e-05	7.64e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CCND1—kidney cancer	3.68e-05	7.44e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—JUN—kidney cancer	3.67e-05	7.43e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CTNNB1—kidney cancer	3.64e-05	7.37e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PTEN—kidney cancer	3.55e-05	7.18e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—VEGFA—kidney cancer	3.21e-05	6.49e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—MAPK3—kidney cancer	3.04e-05	6.14e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—MYC—kidney cancer	2.95e-05	5.97e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—MAPK1—kidney cancer	2.89e-05	5.84e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—KRAS—kidney cancer	2.73e-05	5.52e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PIK3CA—kidney cancer	2.51e-05	5.07e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—TP53—kidney cancer	2.42e-05	4.9e-05	CbGpPWpGaD
